Form 4: Carlyle Group Sells QuidelOrtho Corp Shares Under 10b5-1 Trading Plan

The Carlyle Group Inc. reports the sale of QuidelOrtho Corp shares across multiple transactions executed between July 26 and July 29, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• The Carlyle Group Inc. has reported the sale of QuidelOrtho Corp shares.
• The sales occurred between July 26 and July 29, 2024.
• The transactions were executed under a Rule 10b5-1 trading plan adopted on May 12, 2024.
• On July 26, 2024, 39,707 shares were sold at a weighted average price of $38.7533, with prices ranging from $38.12 to $38.9983.
• Also on July 26, 2024, 64,219 shares were sold at a weighted average price of $39.2334, with prices ranging from $39.00 to $39.77.
• On July 29, 2024, 142,269 shares were sold at a weighted average price of $38.8341, with prices ranging from $38.095 to $38.9995.
• Additionally, on July 29, 2024, 15,821 shares were sold at a weighted average price of $39.0204, with prices ranging from $39.00 to $39.08.
• Following these transactions, Carlyle Partners VI Cayman Holdings, L.P. indirectly holds 9,444,215 shares.
• The Carlyle Group Inc. disclaims beneficial ownership of these securities.

Sentiment

Score: 5

Explanation: This is a neutral report on share sales by a major shareholder. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This Form 4 filing indicates activity by a major shareholder, The Carlyle Group, in the market for QuidelOrtho Corp shares. Such transactions are common and provide insight into the investment strategies of large institutional holders.

Stakeholder Impact

• The sale of shares by a major holder like Carlyle Group could potentially influence the stock price in the short term.
• The transactions are part of a pre-planned trading strategy, which may reassure stakeholders that the sales are not based on sudden negative insights.

Key Dates